SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX)

US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
$0.12-$0.01 (-7.55%)
 
Market cap
$2.75M
Insider Score
Health Score
Listed since
Mar 21, 2023
Market Cap$2.75M-89.3%
Revenue (ttm)$300.48K-35.6%
Net Income-$11.04M+44.3%
EPS-$0.67+76.6%
Shares Out22.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume241,271
Open$0.13
Previous Close$0.13
Day's Range$0.12 - $0.14
52-Week Range$0.12 - $1.38
Beta2.15
Analystsn/a
Price Targetn/a
Earnings Daten/a
-10.25% (1D)
No price history available.

About MGRX

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

Address
15110 North Dallas Parkway, Dallas, TX, 75248, US
Market Cap
3 million
Employees
3
Industrial Classification
Medical - Healthcare Information Services

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$174.01K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From MGRX’s reported statements · Q3 2026 (trailing 12 months)
1 Day
-7.55%
5 Days
-21.02%
1 Month
-49.41%
6 Months
-72.59%
1 Year
-89.25%

$MGRX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in MGRX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by MGRX's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

MGRX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New MGRX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to MGRX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in MGRX

VXFVanguard Extended Market ETF$28.72K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from MGRX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
4
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.